{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:08:32Z","timestamp":1790791712530,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA256006"],"award-info":[{"award-number":["R01CA256006"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA127001"],"award-info":[{"award-number":["P50CA127001"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA283514"],"award-info":[{"award-number":["R21CA283514"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008221","name":"Cure Starts Now Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000953","name":"Alliance for Cancer Gene Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.200976","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:48:41Z","timestamp":1742672921000},"page":"200976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The multilayered control of acetylation during adenovirus-based immunotherapy of cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Akhila","family":"Parthasarathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candelaria","family":"Gomez-Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-2335","authenticated-orcid":false,"given":"Juan","family":"Fueyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.200976_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113354","article-title":"Oncolytic Adenovirus in Cancer Immunotherapy","volume":"12","author":"Peter","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.200976_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/95.9.652","article-title":"Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway","volume":"95","author":"Fueyo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2025.200976_bib3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.mt.6300239","article-title":"Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway","volume":"15","author":"Cascallo","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200976_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2025.200976_bib5","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma","volume":"386","author":"Gallego Perez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200976_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-023-02347-y","article-title":"Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1\/2 trial","volume":"29","author":"Nassiri","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.200976_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ymthe.2024.01.035","article-title":"Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice","volume":"32","author":"Shin","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2025.200976_bib8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1155544","article-title":"Adenovirus small e1a alters global patterns of histone modification","volume":"321","author":"Horwitz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200976_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00805-18","article-title":"Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters","volume":"92","author":"Hsu","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200976_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.chom.2014.10.004","article-title":"Adenovirus small E1A employs the lysine acetylases p300\/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection","volume":"16","author":"Ferrari","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omton.2025.200976_bib11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/onc.2010.461","article-title":"Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A","volume":"30","author":"Savelyeva","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v15010161","article-title":"Human Adenovirus Gene Expression and Replication Is Regulated through Dynamic Changes in Nucleoprotein Structure throughout Infection","volume":"15","author":"Jennings","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.200976_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0092-8674(00)80552-8","article-title":"A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity","volume":"96","author":"Chakravarti","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200976_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80553-X","article-title":"Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A","volume":"96","author":"Hamamori","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200976_bib15","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/j.1460-2075.1995.tb07356.x","article-title":"Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells","volume":"14","author":"Kitabayashi","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.200976_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/24190","article-title":"Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A","volume":"396","author":"Ait-Si-Ali","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200976_bib17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1155546","article-title":"Epigenetic reprogramming by adenovirus e1a","volume":"321","author":"Ferrari","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200976_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1101\/gr.132308.111","article-title":"Reorganization of the host epigenome by a viral oncogene","volume":"22","author":"Ferrari","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2025.200976_bib19","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1038\/onc.2008.181","article-title":"p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc","volume":"27","author":"Sankar","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib20","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1128\/JVI.00289-12","article-title":"Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation","volume":"86","author":"Ablack","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200976_bib21","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1128\/JVI.02131-09","article-title":"E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase","volume":"84","author":"Sha","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200976_bib22","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/sj.onc.1206376","article-title":"The adenovirus E1A oncoprotein recruits the cellular TRRAP\/GCN5 histone acetyltransferase complex","volume":"22","author":"Lang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/nar\/gkq783","article-title":"Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression","volume":"39","author":"Komatsu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.200976_bib24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/nar\/gkn1057","article-title":"Transcriptional control by adenovirus E1A conserved region 3 via p300\/CBP","volume":"37","author":"Pelka","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2025.200976_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63512","article-title":"Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP\/p300 inhibition","volume":"10","author":"Hsu","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.omton.2025.200976_bib26","doi-asserted-by":"crossref","first-page":"40554","DOI":"10.1074\/jbc.M004626200","article-title":"E1A12S-mediated activation of the adenovirus type 12 E2 promoter depends on the histone acetyltransferase activity of p300\/CBP","volume":"275","author":"Fax","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200976_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13148-018-0473-4","article-title":"KAT3B-p300 and H3AcK18\/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2","volume":"10","author":"Cocco","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.omton.2025.200976_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28827","article-title":"HBO1\/KAT7\/MYST2 HAT complex regulates human adenovirus replicative cycle","volume":"10","author":"Kamel","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.omton.2025.200976_bib29","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/onc.2012.534","article-title":"Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA","volume":"32","author":"Gupta","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/35083062","article-title":"Acetylation control of the retinoblastoma tumour-suppressor protein","volume":"3","author":"Chan","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omton.2025.200976_bib31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1101\/gad.7.8.1559","article-title":"Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts","volume":"7","author":"Quelle","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.omton.2025.200976_bib32","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1093\/emboj\/20.21.6095","article-title":"A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300","volume":"20","author":"Vries","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2025.200976_bib33","doi-asserted-by":"crossref","first-page":"16428","DOI":"10.1074\/jbc.M600038200","article-title":"Coordinate inhibition of cytokine-mediated induction of ferritin H, manganese superoxide dismutase, and interleukin-6 by the adenovirus E1A oncogene","volume":"281","author":"Jennings-Gee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200976_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/jvi.35.3.637-643.1980","article-title":"Acetylation of histone-like proteins of adenovirus type 5","volume":"35","author":"Fedor","year":"1980","journal-title":"J. Virol."},{"key":"10.1016\/j.omton.2025.200976_bib35","doi-asserted-by":"crossref","first-page":"14323","DOI":"10.1073\/pnas.011283598","article-title":"Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200976_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virol.2009.05.024","article-title":"Identification of a second independent binding site for the pCAF acetyltransferase in adenovirus E1A","volume":"391","author":"Pelka","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.200976_bib37","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M207512200","article-title":"Acetylation of the adenovirus-transforming protein E1A determines nuclear localization by disrupting association with importin-alpha","volume":"277","author":"Madison","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200976_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature18317","article-title":"A core viral protein binds host nucleosomes to sequester immune danger signals","volume":"535","author":"Avgousti","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200976_bib39","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2003-09-3131","article-title":"Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators","volume":"103","author":"Deng","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200976_bib40","doi-asserted-by":"crossref","first-page":"25401","DOI":"10.1074\/jbc.M213037200","article-title":"Interferon regulatory factor-2 regulates cell growth through its acetylation","volume":"278","author":"Masumi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200976_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncb747","article-title":"IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff","volume":"4","author":"Paulson","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omton.2025.200976_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.virol.2006.04.036","article-title":"E1A is the component of the MHC class I enhancer complex that mediates HDAC chromatin repression in adenovirus-12 tumorigenic cells","volume":"352","author":"Zhao","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.omton.2025.200976_bib43","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V99.6.2248","article-title":"Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells","volume":"99","author":"Kitazono","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200976_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1535-7163.MCT-06-0431","article-title":"The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems","volume":"6","author":"Goldsmith","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.omton.2025.200976_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127058","article-title":"The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells","volume":"10","author":"Berghauser Pont","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2025.200976_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/v14051006","article-title":"HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad\u0394\u0394 and Ad-3\u0394-A20T in Pancreatic and Triple-Negative Breast Cancer Models","volume":"14","author":"Rodriguez","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2025.200976_bib47","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1038\/onc.2010.295","article-title":"Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulation","volume":"29","author":"Yamaguchi","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib48","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.1074\/jbc.RA119.011006","article-title":"HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21","volume":"295","author":"Xie","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200976_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051210","article-title":"Advantages of Using Paclitaxel in Combination with Oncolytic Adenovirus Utilizing RNA Destabilization Mechanism","volume":"12","author":"Hossain","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.200976_bib50","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/onc.2010.335","article-title":"Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer","volume":"29","author":"Ingemarsdotter","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200976_bib51","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.18632\/oncotarget.2510","article-title":"De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells","volume":"5","author":"Chang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2025.200976_bib52","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1245\/s10434-014-4061-3","article-title":"E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer","volume":"22","author":"Chen","year":"2015","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.omton.2025.200976_bib53","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u0394 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2025.200976_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1115641","article-title":"First oncolytic virus approved for melanoma immunotherapy","volume":"5","author":"Pol","year":"2016","journal-title":"OncoImmunology"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:06:50Z","timestamp":1762657610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000451"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.200976","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multilayered control of acetylation during adenovirus-based immunotherapy of cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.200976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200976"}}